||The CCPR decided to advance all draft MRLs to Step 8 and to revoke all interim CXLs once the MRLs have been adopted by the CAC (CCPR 38:128). The CAC revoked all MRLs as proposed by CCPR in Appendix VII to ALINORM 06/29/24. However this Appendix does not list the Interim MRLs for Fludioxonil to be revoked by the CAC (CAC 29:Appendix VII). As regards Interim MRLs, the CAC noted that CCPR had agreed on new policies to expedite the MRL setting process and approved discontinuation of work on interim MRLs (29:137 & Appendix IX). The CCPR is invited to consider revocation of this MRL.